Conference Information
Scientific Sessions
Session 01: Neurology
Neurology is the branch of medicine that deals with the diseases of the brain and the central and the peripheral nervous systems. Neurologists are the physicians who are trained in diagnosing, treating and managing patients with neurological disorders. The most important task to manage the global burden of neurological disorders is to have a clear-cut view of the Epidemiology of the nervous disorders. And for which the simple ‘head count’ method will not be as effective as the statistical assessments and projections of the burden of health conditions and diseases. There are more than 600 neurological disorders and for recognizing the signs and symptoms of neurological problems, it is first important to distinguish the various types of neurological disorders and infections of the nervous system. Stroke is a leading cause of death among the world population and it attacks both adults and children. Stroke is the most common presentation of Cerebrovascular disease. If a blockage, malformation, or haemorrhage in blood vessels prevents the brain cells from getting enough oxygen, brain damage can result. Cerebrovascular diseases can develop in various ways, including deep vein thrombosis (DVT) and atherosclerosis, where plaque builds up in the arteries. Stroke, transient ischemic attack, aneurysms, and vascular malformations are all types of cerebrovascular disease. Other examples include a narrowing or blockage in the carotid, intracranial, or vertebral arteries, known as stenosis.
Related Conferences:
World Congress on Dementia and Alzheimer Rehabilitation, November 27-29, 2018, Athens, Greece | International Conference on Spine Surgery, November 01-02, 2018, Brussels, Belgium | International Conference on Frontotemporal Dementias, November 11-14, 2018, Sydney, Australia| Asian Oceanian Congress of Neurology, November 08-11, 2018, Seoul, South Korea | International Conference on Brain Stimulation, November 26-27, 2018, Tokyo, Japan | International Conference on Neurosurgery and Therapeutics, December 05-06, 2018, Auckland, New Zealand | Congress on Neurodegenerative Diseases: Biology and Therapeutics, November 28- December 01, 2018, New York, USA |
Related Associations and Societies:
European Academy of Neurology | American Academy of Neurology | American Neurological Association | Child Neurology Society | Neurological Society of India | Society for Neuroscience | European Paediatric Neurology Society |
Session 02: Neurogenesis and Neuroplasticity
Neurogenesis observed in the adult human brain suggests the possibility of endogenous neural repair. Neurogenesis the growth and development of neurons and process is most active while a baby is developing in the womb and is responsible for the production of the brain’s neurons. Neurogenesis takes place in the subventricular zone (SVZ) that forms the lining of the lateral ventricles and the sub granular zone that forms part of the dentate gyrus of the hippocampus area. The stem cells that proliferate in the ventricular zone of the neural tube are the source of two major families of cells in the nervous system: the neurons and the glial cells. Hippocampus is also identified as one of the neurogenic zones and Hippocampal neurogenesis is important as it is involved in cognitive function, memory process and affective behaviour. Neuroplasticity is the ability of the brain to form new neural connections throughout life and it allows the nerve cells to compensate for brain injury and disease and adjust to changes and new environment. Mechanisms of neuroplasticity can impact the aspects of recovery after brain injury and helps to understand whether behavioural improvement reflects true behavioural recovery or the behavioural changes are simply due to the use of compensatory strategies.
Related Conferences:
International Conference on Neurology and Brain Disorders, November 15-16, 2018, Osaka, Japan | International Conference on Alzheimer’s Disease and Dementia, October 29-31, 2018, Valencia, Spain | Joint Global Neurofibromatosis Conference, November 2-6, 2018, Paris, France | International Symposium on Neuroprotection and Neurorepair, October 9-11, 2018, Dresden, Germany | Annual Pain and Migraine Therapeutics Summit, October 10-11, 2018, San Francisco, USA | European Academy of Neurology Congress, June 16-19, 2018, Lisbon, Portugal | International Congress on Neuromuscular Diseases, July 06-10, 2018, Vienna, Austria |
Related Associations and Societies:
European Federation of Neurological Societies | The Association of British Neurologists | Southern Clinical Neurological Society | European Federation of Neurological Associations | Texas Neurological Society | The Wisconsin Neurological Society | Canadian Neurological Society |
Session 03: Neurogenetics and Evolutionary Behavior
Neurogenetics has helped in understanding the mechanisms that cause brain disorders. Neurogenetics has also paved way for accurate molecular diagnoses and knowledge of the genes and pathways that are involved in many neurological and psychiatric disorders. Newer methods and analytical approaches like genome array studies and next-generation sequencing technologies helps to understand the complexities of the genetic architecture that determines our risks for these disorders. Various neural and genetic components contribute to the behaviour of humans and it has become more important to have deeper insights about their neural bases. An important aspect of Behavioural neuroscience is the Evolutionary psychology. Behavioural neuroscience studies the relation between biological and psychological function. Evolutionary psychology focusses on how evolution has affected human mind and behaviour. It emphasizes the need of Adaptation, Reproduction and Survival of the fittest. Neurodevelopmental disorders are the brain function disorders which affect the emotions, memory, learning and behaviour of individuals. These disorders may be caused by genetic factors like chromosomal abnormalities.
Related Conferences:
World Congress on Neurology and Neurodisorders, July 16-17, 2018, Melbourne, Australia | Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018, Tokyo, Japan | International Congress of Parkinson’s Diseases and Movement Disorders, October 05-09, 2018, Hong Kong | World Stroke Congress, October 17-20, 2018, Montreal, Canada | World Congress of Neurology, October 26-31, 2018, Dubai, United Arab Emirates | Conference on Advances in Neurodegenerative Diseases Research and Therapy, June 17-21, 2018, Colorado, US | World Congress on Paediatric Neurology, October 01-02, 2018, Osaka, Japan |
Related Associations and Societies:
The New York State Neurological Society | Washington State Neurological Society | The Japanese Society of Psychiatry and Neurology | Neurological Foundation of New Zealand | The Australia and New Zealand Child Neurology Society | Georgia Neurological Society | The Florida Society of Neurology |
Session 04: Neurotoxicity and Biochemical Aspects
Neurotoxicity is the poisoning or damage of the brain and the nervous system caused by the exposure to toxic substances or chemicals. Neurotoxicity can drastically diminish the abilities of the person like learning, perceiving, controlling emotions, etc., without being identified by any imaging examinations. Neurotoxic effects can be reversible or irreversible. There are various neurotoxic syndromes affecting humans, Neuropathies being the most important. The types of neurotoxic syndromes include Neuronopathies, Axonopathies, Myelinopathies and Neurotransmission- associated neuropathies. CIPN (Chemotherapy-Induced Peripheral Neuropathy) is a major disorder. Peripheral neuropathy may be caused by chemotherapy drugs that affect the peripheral nerves. Neurotoxicity can be caused by a range of chemicals including heavy metals like lead and mercury. Neurotoxicity is found to have effects like Hypoxia on the biochemical mechanisms in human and may affect various metabolic activities. Peripheral neuropathy may be caused by chemotherapy drugs that affect the peripheral nerves.
Related Conferences:
World Congress on Dementia and Alzheimer Rehabilitation, November 27-29, 2018, Athens, Greece | International Conference on Spine Surgery, November 01-02, 2018, Brussels, Belgium | International Conference on Frontotemporal Dementias, November 11-14, 2018, Sydney, Australia| Asian Oceanian Congress of Neurology, November 08-11, 2018, Seoul, South Korea | International Conference on Brain Stimulation, November 26-27, 2018, Tokyo, Japan | International Conference on Neurosurgery and Therapeutics, December 05-06, 2018, Auckland, New Zealand | Congress on Neurodegenerative Diseases: Biology and Therapeutics, November 28- December 01, 2018, New York, USA |
Related Associations and Societies:
European Academy of Neurology | American Academy of Neurology | American Neurological Association | Child Neurology Society | Neurological Society of India | Society for Neuroscience | European Paediatric Neurology Society |
Session 05: Nutritional Neuroscience
Poor nutrition, particularly in early life, can have lasting effects on brain functioning and cognitive performance. Nutritional neuroscience deals with the role of various components of the normal diet like protein, carbohydrate, fat, dietary supplements like minerals, vitamins, hormones, and food additives like artificial flavours, colours, sweeteners on neurochemistry, neurobiology, behaviour, and performance. With nutrients affecting the brain development of humans, it is necessary to study the effects of meals on cognitive behaviour. Sugar is the major component of daily diet of most of the people and many people have developed addiction to sugar. Sugar is found to release opioids and dopamine and hence causes addiction potential. Addiction may cause neurochemical changes that are related to behaviour. ADHD (Attention Deficit Hyperactivity Disorder) is a common neurobehavioral disorder of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD have trouble in paying attention, controlling impulsive behaviours or will be hyperactive. Although ADHD can’t be cured, it can be successfully managed, and some symptoms may improve as the child ages.
Related Conferences:
International Conference on Neurology and Brain Disorders, November 15-16, 2018, Osaka, Japan | International Conference on Alzheimer’s Disease and Dementia, October 29-31, 2018, Valencia, Spain | Joint Global Neurofibromatosis Conference, November 2-6, 2018, Paris, France | International Symposium on Neuroprotection and Neurorepair, October 9-11, 2018, Dresden, Germany | Annual Pain and Migraine Therapeutics Summit, October 10-11, 2018, San Francisco, USA | European Academy of Neurology Congress, June 16-19, 2018, Lisbon, Portugal | International Congress on Neuromuscular Diseases, July 06-10, 2018, Vienna, Austria |
Related Associations and Societies:
European Federation of Neurological Societies | The Association of British Neurologists | Southern Clinical Neurological Society | European Federation of Neurological Associations | Texas Neurological Society | The Wisconsin Neurological Society | Canadian Neurological Society |
Session 06: Psychopathology and Psychoactive Drugs
Psychopathology is the study of abnormal behaviour. It may be defined as the study of psychological and behavioural distress, dysfunction and disability. Psychopathologic disorders can be both somatogenic and psychogenic. Schizophrenia is the most common psychological disorder and is characterised by hallucinations, delusions and disorganised thoughts. Psychosis is another serious mental disorder that have symptoms like false beliefs, sleep problems, incoherent speech and social withdrawal. Psychoactive drugs are the chemical substances that act on the central nervous system altering the brain functions temporarily. They can be used recreationally to improve one’s consciousness or as medications. Overuse or abuse of these drugs can result in addiction and other risks.
Related Conferences:
World Congress on Neurology and Neurodisorders, July 16-17, 2018, Melbourne, Australia | Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018, Tokyo, Japan | International Congress of Parkinson’s Diseases and Movement Disorders, October 05-09, 2018, Hong Kong | World Stroke Congress, October 17-20, 2018, Montreal, Canada | World Congress of Neurology, October 26-31, 2018, Dubai, United Arab Emirates | Conference on Advances in Neurodegenerative Diseases Research and Therapy, June 17-21, 2018, Colorado, US | World Congress on Paediatric Neurology, October 01-02, 2018, Osaka, Japan |
Related Associations and Societies:
The New York State Neurological Society | Washington State Neurological Society | The Japanese Society of Psychiatry and Neurology | Neurological Foundation of New Zealand | The Australia and New Zealand Child Neurology Society | Georgia Neurological Society | The Florida Society of Neurology |
Session 07: Neurodegenerative Disorders
Neurodegenerative disorders results from the loss of neurons within the brain and nervous system. Neurons do not reproduce or replace themselves and hence when they die or get damaged, they can’t be replaced by the body. This results in Ataxias or Dementias. Dementias are largely responsible for the global neurological burden and Alzheimer’s disease is the reason for 60-70% of dementia cases. Major neurodegenerative disorders include Alzheimer’s disease, Parkinson’s disease, Huntington’s chorea, Prion diseases, Spinocerebellar Ataxia, Hydrocephalus, Spinal Muscular Atrophy.
Related Conferences:
World Congress on Dementia and Alzheimer Rehabilitation, November 27-29, 2018, Athens, Greece | International Conference on Spine Surgery, November 01-02, 2018, Brussels, Belgium | International Conference on Frontotemporal Dementias, November 11-14, 2018, Sydney, Australia| Asian Oceanian Congress of Neurology, November 08-11, 2018, Seoul, South Korea | International Conference on Brain Stimulation, November 26-27, 2018, Tokyo, Japan | International Conference on Neurosurgery and Therapeutics, December 05-06, 2018, Auckland, New Zealand | Congress on Neurodegenerative Diseases: Biology and Therapeutics, November 28- December 01, 2018, New York, USA |
Related Associations and Societies:
European Academy of Neurology | American Academy of Neurology | American Neurological Association | Child Neurology Society | Neurological Society of India | Society for Neuroscience | European Paediatric Neurology Society |
Session 08: Neurosurgery
Neurosurgery is a medical speciality that deals with diagnosing and treating injuries and disorders of the brain, spinal cord and nerves. Neurosurgeons are trained in all aspects of neurosurgery, including the cerebrovascular system, the spine and spinal cord, trauma, tumors, pain management and paediatric surgery. Brain edema, seizures, postoperative hemorrhage, and cerebral ischemia can complicate neurosurgical procedures. There are many forms of neurosurgery including neurovascular surgery, key hole brain surgery, etc. Spine deformities can be treated by surgical methods. Spine deformities can be defined as the abnormality in formation, alignment and shape of the vertebral column. Spine stabilization surgery is recommended in cases where there is severe pain, neurological problems, or curvature greater than 50 degrees. The goal of surgery is to straighten spine. Several surgical techniques can be used, including spinal fusion (fusing the vertebrae together) and the use of implants to secure the fusion.
Related Conferences:
International Conference on Neurology and Brain Disorders, November 15-16, 2018, Osaka, Japan | International Conference on Alzheimer’s Disease and Dementia, October 29-31, 2018, Valencia, Spain | Joint Global Neurofibromatosis Conference, November 2-6, 2018, Paris, France | International Symposium on Neuroprotection and Neurorepair, October 9-11, 2018, Dresden, Germany | Annual Pain and Migraine Therapeutics Summit, October 10-11, 2018, San Francisco, USA | European Academy of Neurology Congress, June 16-19, 2018, Lisbon, Portugal | International Congress on Neuromuscular Diseases, July 06-10, 2018, Vienna, Austria |
Related Associations and Societies:
European Federation of Neurological Societies | The Association of British Neurologists | Southern Clinical Neurological Society | European Federation of Neurological Associations | Texas Neurological Society | The Wisconsin Neurological Society | Canadian Neurological Society |
Session 09: Neuroinformatics
Neuroinformatics is a combination of neuroscience and information science. It deals with the organisation of neuroscience data and knowledge bases of nervous system and application of tools and computational models for data analysis, acquisition, visualization and distribution. Brain mapping helps the scientists to know what the brain does and how various parts of the brain work. Brain mapping is a set of neuroscience techniques used to view the structural and functional aspects of the brain onto a spatial representation called maps. Due to the advancements and research in the field of neuroinformatics, large amount of data is being analysed and interpreted using various tools.
Related Conferences:
World Congress on Neurology and Neurodisorders, July 16-17, 2018, Melbourne, Australia | Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018, Tokyo, Japan | International Congress of Parkinson’s Diseases and Movement Disorders, October 05-09, 2018, Hong Kong | World Stroke Congress, October 17-20, 2018, Montreal, Canada | World Congress of Neurology, October 26-31, 2018, Dubai, United Arab Emirates | Conference on Advances in Neurodegenerative Diseases Research and Therapy, June 17-21, 2018, Colorado, US | World Congress on Paediatric Neurology, October 01-02, 2018, Osaka, Japan |
Related Associations and Societies:
The New York State Neurological Society | Washington State Neurological Society | The Japanese Society of Psychiatry and Neurology | Neurological Foundation of New Zealand | The Australia and New Zealand Child Neurology Society | Georgia Neurological Society | The Florida Society of Neurology |
Session 10: Neuroimmunology
Neuroimunology is a field which combines neuroscience and immunology. The interaction between nervous system and immune system can be described by Neuroimmunology. Immune cells usually release biochemicals to neutralize foreign particles and signal other components of the immune system to react. When the immune system attacks the body’s own tissue, the nervous system is affected in some of the Autoimmune diseases. Neuroimmunlogical disorders namely Multiple Sclerosis, Myasthenia Gravis, and acute inflammatory polyneuropathy (Guillain-Barré syndrome), are autoimmune and may be caused due to disorders of immunoregulation. HIV-associated dementia is caused by neuronal damage by the HIV virus. Few autoimmune diseases are mediated by autoantibodies. Paraneoplastic syndromes are also caused by autoimmunity and are associated with cancer, not by direct invasion or tumors. Neuroglial cells participate in immune responses within the central nervous system.
Related Conferences:
World Congress on Dementia and Alzheimer Rehabilitation, November 27-29, 2018, Athens, Greece | International Conference on Spine Surgery, November 01-02, 2018, Brussels, Belgium | International Conference on Frontotemporal Dementias, November 11-14, 2018, Sydney, Australia| Asian Oceanian Congress of Neurology, November 08-11, 2018, Seoul, South Korea | International Conference on Brain Stimulation, November 26-27, 2018, Tokyo, Japan | International Conference on Neurosurgery and Therapeutics, December 05-06, 2018, Auckland, New Zealand | Congress on Neurodegenerative Diseases: Biology and Therapeutics, November 28- December 01, 2018, New York, USA |
Related Associations and Societies:
European Academy of Neurology | American Academy of Neurology | American Neurological Association | Child Neurology Society | Neurological Society of India | Society for Neuroscience | European Paediatric Neurology Society |
Session 11: Neurotransmission and Neuroinflammation
Neurotransmission is the process of information transfer between neurons and their targets. It regulates both excitatory and inhibitory functions in the central nervous system. Neurotransmitters are the chemical messengers that transmit signals from neurons to target cells across the synapse. The process of neurotransmission includes various stages like synthesis, storage, release, binding and inactivation. Various diseases associated with neurotransmitters include Epilepsy, Migraines, ADD, etc., Neuroinflammation is the inflammation of the nervous tissue. Neuroinflammation may be initiated in response to infection, brain injury, toxic metabolites, or autoimmunity. The two types include Acute and Chronic neuroinflammation. As neuroinflammation is associated with many neurodegenerative disorders, future research works include identifying the potential drug targets for reducing neuroinflammation.
Related Conferences:
International Conference on Neurology and Brain Disorders, November 15-16, 2018, Osaka, Japan | International Conference on Alzheimer’s Disease and Dementia, October 29-31, 2018, Valencia, Spain | Joint Global Neurofibromatosis Conference, November 2-6, 2018, Paris, France | International Symposium on Neuroprotection and Neurorepair, October 9-11, 2018, Dresden, Germany | Annual Pain and Migraine Therapeutics Summit, October 10-11, 2018, San Francisco, USA | European Academy of Neurology Congress, June 16-19, 2018, Lisbon, Portugal | International Congress on Neuromuscular Diseases, July 06-10, 2018, Vienna, Austria |
Related Associations and Societies:
European Federation of Neurological Societies | The Association of British Neurologists | Southern Clinical Neurological Society | European Federation of Neurological Associations | Texas Neurological Society | The Wisconsin Neurological Society | Canadian Neurological Society |
Session 12: Neuromuscular Diseases
Neuromuscular diseases are the diseases which impair the functioning of muscles either directly by affecting the voluntary muscles or by affecting the nerves or neuromuscular junctions. Progressive muscle weakness is the condition in these diseases. Neuromuscular diseases can be classified as diseases of the Neuromuscular junction, Anterior horn cell disorders, Motor neuron diseases etc. In order to diagnose these diseases, Electromyography must be done. During Electromyography, small electric impulses are given to the nerves and electrical responses are recorded. This helps to identify the loss of nerve fibres and problems of insulation of nerves.
Related Conferences:
World Congress on Neurology and Neurodisorders, July 16-17, 2018, Melbourne, Australia | Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018, Tokyo, Japan | International Congress of Parkinson’s Diseases and Movement Disorders, October 05-09, 2018, Hong Kong | World Stroke Congress, October 17-20, 2018, Montreal, Canada | World Congress of Neurology, October 26-31, 2018, Dubai, United Arab Emirates | Conference on Advances in Neurodegenerative Diseases Research and Therapy, June 17-21, 2018, Colorado, US | World Congress on Paediatric Neurology, October 01-02, 2018, Osaka, Japan |
Related Associations and Societies:
The New York State Neurological Society | Washington State Neurological Society | The Japanese Society of Psychiatry and Neurology | Neurological Foundation of New Zealand | The Australia and New Zealand Child Neurology Society | Georgia Neurological Society | The Florida Society of Neurology |
Session 13: Neuro Examination Techniques
Neurological examination is done to identify the presence of abnormality and locate the abnormality within the nervous system. Computed Tomography and Magnetic Resonance Imaging are major imaging methods used for neurodiagnosis. MRI is used to detect intracranial and intraspinal abnormalities. Electro Encephalo Graphy(EEG) measures the brain electric activity. Traditional EEG machines are gradually being replaced by computerized systems that convert EEG data into digital format. Electromyography and Nerve conduction studies help in differentiating neurogenic and myogenic disorders. Abnormalities in nerve conduction helps in identifying Neuropathies. Cerebro Spinal Fluid examination provides the differential diagnosis of CNS infections, meningitis, encephalitis, etc. CSF examination also helps in detecting intracranial bleeding. Biopsy and DNA examinations also help in effective diagnosis of neurological disorders.
Related Conferences:
World Congress on Dementia and Alzheimer Rehabilitation, November 27-29, 2018, Athens, Greece | International Conference on Spine Surgery, November 01-02, 2018, Brussels, Belgium | International Conference on Frontotemporal Dementias, November 11-14, 2018, Sydney, Australia| Asian Oceanian Congress of Neurology, November 08-11, 2018, Seoul, South Korea | International Conference on Brain Stimulation, November 26-27, 2018, Tokyo, Japan | International Conference on Neurosurgery and Therapeutics, December 05-06, 2018, Auckland, New Zealand | Congress on Neurodegenerative Diseases: Biology and Therapeutics, November 28- December 01, 2018, New York, USA |
Related Associations and Societies:
European Academy of Neurology | American Academy of Neurology | American Neurological Association | Child Neurology Society | Neurological Society of India | Society for Neuroscience | European Paediatric Neurology Society |
Session 14: Neuro Oncology and Stem Cell Therapies
Neuro oncology deals with brain and spinal tumors. Gliomas are the important causes of tumors. Brain tumors are responsible for severe cognitive and physical disability and accounts for high malignancy rates. Tumors can also cause brain lesions or spinal lesions. Lesions are damaged tissues caused by injury, infection or exposure to certain chemicals. Treatment of tumors depends on the type, location and size of the tumors as well as the age of patients. Tumors can be treated surgically or by chemotherapy or radiotherapy. Stem Cells can be used in the treatment of neurodegenerative diseases. The transplantation of embryonic neurons or stem cells that offers potential treatment strategy for neurodegenerative disorders such as Parkinson's disease, Huntington's disease (HD), and Alzheimer's disease.
Related Conferences:
International Conference on Neurology and Brain Disorders, November 15-16, 2018, Osaka, Japan | International Conference on Alzheimer’s Disease and Dementia, October 29-31, 2018, Valencia, Spain | Joint Global Neurofibromatosis Conference, November 2-6, 2018, Paris, France | International Symposium on Neuroprotection and Neurorepair, October 9-11, 2018, Dresden, Germany | Annual Pain and Migraine Therapeutics Summit, October 10-11, 2018, San Francisco, USA | European Academy of Neurology Congress, June 16-19, 2018, Lisbon, Portugal | International Congress on Neuromuscular Diseases, July 06-10, 2018, Vienna, Austria |
Related Associations and Societies:
European Federation of Neurological Societies | The Association of British Neurologists | Southern Clinical Neurological Society | European Federation of Neurological Associations | Texas Neurological Society | The Wisconsin Neurological Society | Canadian Neurological Society |
Session 15: Muscle Receptors and Nerve Reflexes
Reflexes are automatic and subconscious reponses to changes within and outside the body. It involves sensing a stimulus and generating appropriate response. Reflex arc governs the operation of reflexes and its function is to perform automatic responses without conscious thought. The major components of the reflex arc includes receptor, sensory neuron, interneuron, motor neuron and effector organ. The types of reflexes include Stretch reflex, Golgi tendon reflex, Withdrawal or flexor reflex. Reflex epilepsy is a form of reflex seizure caused by external stimulus or internal mental processes. Ataxia is the lack of muscle control and coordination of voluntary muscles. Neuralgia is a severe pain caused by damaged nerve caused by inflammation or injury.
Related Conferences:
World Congress on Neurology and Neurodisorders, July 16-17, 2018, Melbourne, Australia | Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018, Tokyo, Japan | International Congress of Parkinson’s Diseases and Movement Disorders, October 05-09, 2018, Hong Kong | World Stroke Congress, October 17-20, 2018, Montreal, Canada | World Congress of Neurology, October 26-31, 2018, Dubai, United Arab Emirates | Conference on Advances in Neurodegenerative Diseases Research and Therapy, June 17-21, 2018, Colorado, US | World Congress on Paediatric Neurology, October 01-02, 2018, Osaka, Japan |
Related Associations and Societies:
The New York State Neurological Society | Washington State Neurological Society | The Japanese Society of Psychiatry and Neurology | Neurological Foundation of New Zealand | The Australia and New Zealand Child Neurology Society | Georgia Neurological Society | The Florida Society of Neurology |
Session 16: Trauma and Rehabilitation
Traumatic Brain Injury (TBI) is a complex injury with a broad spectrum of symptoms and disabilities. TBI may also cause Spinal Cord Injury. TBI is the insult to the brain caused by trauma to the head (head injury). Acquired injuries of the brain can be due to conditions like encephalitis, meningitis, brain tumors, etc., and they are not hereditary or congenital. Mild Traumatic Brain Injury causes symptoms like Headache, Fatigue, Sleep disturbance, decreased concentration, decreased speed of thinking, Memory problems, Depression and anxiety and Emotional mood swings. Severe Brain Injury causes a prolonged unconscious state like Coma, Vegetative State and Locked-in Syndrome. Neurological disorders such as dementias, Parkinson's and tumours and neurological events such as traumatic brain injuries and strokes can be treated by neuro rehabilitation. After the treatment for a brain injury, neuro rehabilitation steps help the patient recover, maximise their functional and cognitive abilities and to help them realise their personal goals and build self-esteem.
Related Conferences:
World Congress on Dementia and Alzheimer Rehabilitation, November 27-29, 2018, Athens, Greece | International Conference on Spine Surgery, November 01-02, 2018, Brussels, Belgium | International Conference on Frontotemporal Dementias, November 11-14, 2018, Sydney, Australia| Asian Oceanian Congress of Neurology, November 08-11, 2018, Seoul, South Korea | International Conference on Brain Stimulation, November 26-27, 2018, Tokyo, Japan | International Conference on Neurosurgery and Therapeutics, December 05-06, 2018, Auckland, New Zealand | Congress on Neurodegenerative Diseases: Biology and Therapeutics, November 28- December 01, 2018, New York, USA |
Related Associations and Societies:
European Academy of Neurology | American Academy of Neurology | American Neurological Association | Child Neurology Society | Neurological Society of India | Society for Neuroscience | European Paediatric Neurology Society |
Session 17: Recent Advancements and Breakthroughs in Neuroscience
The advancements and breakthroughs in neuroscience helps in understanding the brain well and also in effective treatments and diagnoses. Neuromodulation methods like Optogenetics helps in controlling the living cells especially neurons. Optogenetics is a combination of genetics and optics to control the events in cells which show light responses. Wireless EEG (electroencephalogram) sensor technology is rapidly changing the neuroexamination approach. EEG headsets have EEG sensors that measure the brain’s electrical activity, or brainwaves. Traditional EEG testing was invasive and complex. It typically involved the use of silver needles and electrode attachments to the scalp and had to be done in hospitals or research settings. Today, wireless EEG headsets allow readings to be done completely non-invasively. They are simple and comfortable to wear and are powered by a single AAA battery. Gene therapies for treating various neurological disorders seems to be promising.
Related Conferences:
International Conference on Neurology and Brain Disorders, November 15-16, 2018, Osaka, Japan | International Conference on Alzheimer’s Disease and Dementia, October 29-31, 2018, Valencia, Spain | Joint Global Neurofibromatosis Conference, November 2-6, 2018, Paris, France | International Symposium on Neuroprotection and Neurorepair, October 9-11, 2018, Dresden, Germany | Annual Pain and Migraine Therapeutics Summit, October 10-11, 2018, San Francisco, USA | European Academy of Neurology Congress, June 16-19, 2018, Lisbon, Portugal | International Congress on Neuromuscular Diseases, July 06-10, 2018, Vienna, Austria |
Related Associations and Societies:
European Federation of Neurological Societies | The Association of British Neurologists | Southern Clinical Neurological Society | European Federation of Neurological Associations | Texas Neurological Society | The Wisconsin Neurological Society | Canadian Neurological Society |
Session 18: Challenges in Neuroscience
Neuroscience is a challenging field that requires expertise of neurologists and neurosurgeons in diagnoses and treatment of diseases and injuries of brain and nervous system. There are day-to-day challenges that makes the work of neurologists and neurosurgeons complex and demanding, with rapidly changing tasks in assessing, diagnosing, treating and managing the patients. Imaging of live brain, finding the complete connectome of brain, brain simulation, etc., are still in the phases of research and development.
Related Conferences:
World Congress on Neurology and Neurodisorders, July 16-17, 2018, Melbourne, Australia | Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018, Tokyo, Japan | International Congress of Parkinson’s Diseases and Movement Disorders, October 05-09, 2018, Hong Kong | World Stroke Congress, October 17-20, 2018, Montreal, Canada | World Congress of Neurology, October 26-31, 2018, Dubai, United Arab Emirates | Conference on Advances in Neurodegenerative Diseases Research and Therapy, June 17-21, 2018, Colorado, US | World Congress on Paediatric Neurology, October 01-02, 2018, Osaka, Japan |
Related Associations and Societies:
The New York State Neurological Society | Washington State Neurological Society | The Japanese Society of Psychiatry and Neurology | Neurological Foundation of New Zealand | The Australia and New Zealand Child Neurology Society | Georgia Neurological Society | The Florida Society of Neurology |
About Conference
ICNND 2018 welcomes attendees, presenters, and exhibitors from all over the world to Madrid, Spain. We are delighted to invite you all to attend and register for the “7th International Conference on Neurology and Neuromuscular Diseases” which is going to be held during October 22-23, 2018, Madrid, Spain.
ICNND 2018 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
At PULSUS Group, it is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as Neurologists, Neurosurgeons, Research Scholars and Healthcare professionals from academia &industry making the ICNND 2018 conference a perfect platform.
The conference will be organized around the Theme ‘A zeal for making headway in Neuroscience research’. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Neurology and Neuromuscular Diseases care and share the cross-cultural experiences of various treatment procedures.
ICNND 2018 is an annual meeting of Neurology and Neuromuscular Diseases organizations as well as committees to discuss the future of the neurological disorders in terms of collaboration, structures and organizational development.
2018 Highlights:
-
200+ Participation (70% Industry: 30% Academia)
-
9+ Keynote Speakers
-
30+ Plenary Speakers
-
3+ Exhibitors
-
18 Innovative Educational Sessions
-
B2B Meetings
Why to attend???
With members from around the world focused on learning about Neuroscience and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuroscience community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the Neurological Disorders treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neurodegenerative disorders, evolutionary aspects of neurogenesis, therapeutic techniques and challenges in neuroscience research are hallmarks of this conference.
Target Audience:
- Neurologists
- Psychologists
- Psychiatrists
- Physicians/ General Surgeons
- Neurosurgeons
- Research scholars
- Medical students
- Rehabilitation workers
- Nurses
- Medical technicians
- Orthopaedists
- Counsellors and Physiatrists
- Healthcare and Industrial professionals
- Medical and Healthcare products Manufacturers
- Healthcare marketing agency Executives
- Health services Managers
For Researchers and Faculty Members:
-
Speaker Presentations
-
Poster Display
-
Symposium hosting (4-5 member team)
-
Workshop organizing
For Universities, Associations & Societies:
-
Association Partnering
-
Collaboration proposals
-
Academic Partnering
-
Group Participation
For Students and Research Scholars:
-
Poster Competition (Winner will get Best Poster Award)
-
Young Researcher Forum (YRF Award to the best presenter)
-
Student Attendee
-
Group registrations
For Business Delegates:
-
Speaker Presentations
-
Symposium hosting
-
Book Launch event
-
Networking opportunities
-
Audience participation
For Product Manufacturers:
-
Exhibitor and Vendor booths
-
Sponsorship opportunities
-
Product launch
-
Workshop organizing
-
Scientific Partnering
-
Marketing and Networking with clients
Market Analysis
With the rapid increase in patient population of Neurological Diseases, rising awareness among the public and increased healthcare expenditure, the Europe neurological disorder drugs market is growing tremendously. The burden of neurological disorders has led many pharmaceutical companies to venture into the Europe drug market. The drug market is anticipated to flourish due to the research and development of novel drugs for detrimental diseases like Alzheimer’s disease, Epilepsy, Stroke, Parkinson’s disease, etc.
According to Transparency Market Research, the Europe neurological disorder drugs market was valued at $18.3 billion in 2015 and is expected to reach a valuation of $32.0 billion by the end of 2024. During the forecast period of 2016 and 2024, the global market is projected to expand at CAGR of 6.4%.
It is also predicted that the global market for Alzheimer’s disease therapeutics and diagnostics by region would reach over $6.2 billion by 2020 from $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020.
However, the high cost of research and development and decline in innovation has slowed down the drug development and has limited the market. These factors are expected to retard the growth of the Europe neurological disorder drugs market in the coming years.
IMPORTANCE AND SCOPE:
Neurology deals with the diseases of the Brain and the Nervous System. Neurologists are adept in diagnosing, treating and managing the patients with Nervous Disorders. Another important subspecialty of Neurology is Neuromuscular medicine. Neuromuscular Diseases affect the voluntary muscles either directly by affecting the muscles or by affecting the nerves or neuromuscular junctions. These diseases affect the brain, spinal cord, nerves, their coverings, blood vessels and muscles. The devastating diseases like Brain tumour, Parkinson’s disease and Dementia are the leading causes of deaths globally. With a global increase in neurological burden, Neurology research has become a dynamic area of medicine, with the aim of improving the lives of individuals with neurological disorders. This has led to innovative, collaborative, and interdisciplinary clinical and translational research. The field of Neuroscience integrates researchers from various disciplines including cancer, neuroscience, cardiovascular medicine, transplantation, immunology, bioengineering, and developmental biology. Pondering these thoughtfully, ICNND 2018 renders a great platform for exploring new scientific and clinical frontiers in neuroscience.
MEDICAL UNIVERSITIES IN SPAIN:
- University of Barcelona
- Autonomous University of Barcelona
- University of Navarra
- University of Valencia
- Autonomous University of Madrid
- Pompeu Fabra University
- University of Salamanca
- University of Granada
- Complutense University of Madrid
- University of Santiago of Compostela
- University of Alcalá
- The University of Almería
- The University of Càdiz
COMPANIES IN SPAIN:
- Almirall
- Curaxys
- Inibsa
- Abial
- ADFTecnoGen
- Adhbio
- Allinky Biopharma
- Bionos
- Bioval
- ImmunNovative Developments
- Conda Laboratories
- Mosaic Biomedicals
- Sistemas Genomics
GLOBAL BURDEN OF NEUROLOGICAL DISORDERS:
WORLDWIDE PREVALENCE OF ALZHEIMER'S DISEASE:
